These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 503068)

  • 1. A new biologic activity of histamine: release of a chemotaxis inhibitor from lymphocytes.
    Kownatzki E; Till G; Gemsa D
    Monogr Allergy; 1979; 14():130-3. PubMed ID: 503068
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of histamine on lymphocytes : release of an inhibitor of eosinophil chemotactic migration.
    Kownatzki E; Till G; Gemsa D
    Adv Exp Med Biol; 1979; 114():529-32. PubMed ID: 463658
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of histamine as a modulator of cellular-immune function.
    Rocklin RE
    Monogr Allergy; 1979; 14():134-7. PubMed ID: 503069
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms.
    Ward PA; Dvorak HF; Cohen S; Yoshida T; Data R; Selvaggio SS
    J Immunol; 1975 May; 114(5):1523-31. PubMed ID: 1091704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascaris and eosinophil. II. Isolation and characterization of eosinophil chemotactic factor and neutrophil chemotactic factor of parasite in Ascaris antigen.
    Tanaka J; Baba T; Torisu M
    J Immunol; 1979 Jan; 122(1):302-8. PubMed ID: 762419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delayed hypersensitivity in vitro. 1. Inhibition of the antigen against migration of cells in the spleen and lymph nodes of guinea pigs sensitized to delayed-type hypersensitivity].
    Yoshida T
    Igaku To Seibutsugaku; 1968 Oct; 77(4):123-9. PubMed ID: 5751542
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune mechanisms to Ascaris suum in inbred guinea-pigs. I. Passive transfer of immunity by cells or serum.
    Khoury PB; Stromberg BE; Soulsby EJ
    Immunology; 1977 Apr; 32(4):405-11. PubMed ID: 608676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of chicken eosinophils and their migration response in chick embryos.
    Moriya O; Ichikawa Y
    Dev Comp Immunol; 1982; 6(4):717-26. PubMed ID: 6186538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of eosinophil chemotactic factor (ECF) in basophils and mast cells.
    Czarnetzki B; Sonak R; Macher E
    Monogr Allergy; 1979; 14():281-4. PubMed ID: 503080
    [No Abstract]   [Full Text] [Related]  

  • 11. The mediation of tissue eosinophilia in hypersensitivity reactions. IV. Production of delayed eosinophil chemotactic factor-a by peritoneal exudate cells from sensitized guinea-pigs in vitro.
    Hirashima M; Hirotsu Y; Hayashi H
    Immunology; 1983 Jan; 48(1):69-77. PubMed ID: 6848455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid.
    Sehmi R; Cromwell O; Taylor GW; Kay AB
    J Immunol; 1991 Oct; 147(7):2276-83. PubMed ID: 1655889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-derived eosinophil chemotactic factor. II. Studies on the mechanism of activation of the precursor substance by immune complexes.
    Torisu M; Yoshida T; Ward PA; Cohen S
    J Immunol; 1973 Nov; 111(5):1450-8. PubMed ID: 4126774
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of antibody response in vitro. VII. Enhancing soluble factors for IgG and IgE antibody response.
    Kishimoto T; Ishizaka K
    J Immunol; 1973 Oct; 111(4):1194-205. PubMed ID: 4728681
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
    Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
    J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Macari DM; Teixeira MM; Hellewell PG
    J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mediation of tissue eosinophilia in hypersensitivity reactions. II. Separation of a delayed eosinophil chemotactic factor from macrophage chemotactic factors.
    Hirashima M; Honda M; Hayashi H
    Immunology; 1976 Aug; 31(2):263-71. PubMed ID: 955679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity to Ascaris antigens. 3. Atopic-type hypersensitivity induced in Rhesus monkeys.
    Malley A; Amkraut AA; Strejan G; Campbell DH
    J Immunol; 1968 Aug; 101(2):292-300. PubMed ID: 4174495
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of cytotoxic factor by macrophages from normal guinea pigs.
    Pincus WB
    J Reticuloendothel Soc; 1967 May; 4(2):122-39. PubMed ID: 4168289
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune-specific cytotoxic factor formation by small lymphocytes.
    Pincus WB; Woods WW; Pang RK
    J Reticuloendothel Soc; 1970 Feb; 7(2):220-37. PubMed ID: 5461706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.